Á lódáil...
HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
HER2 is overexpressed in approximately 10%-20% of gastric and gastroesophageal junction carcinomas. In these types of cancer, accurate assessment of HER2 status is mandatory, for selecting patients who may benefit from targeted therapies with anti-HER2 drugs such as Trastuzumab. This manuscript focu...
Na minha lista:
| Foilsithe in: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Baishideng Publishing Group Inc
2016
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4948273/ https://ncbi.nlm.nih.gov/pubmed/27468182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i26.5879 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|